Bis(Disulfide)-Bridged Somatostatin-14 Analogs and Their [<sup>111</sup>In]In-Radioligands: Synthesis and Preclinical Profile.

导出 OA

翻译打印收藏纠错

第一作者： Aikaterini,Tatsi

第一单位： Molecular Radiopharmacy, INRaSTES, NCSR "Demokritos", GR-15341 Athens, Greece.;Department of Pharmacy, University of Patras, GR-26500 Patras, Greece.

作者： Aikaterini,Tatsi ^[1] ; Theodosia,Maina ^[2] ; Beatrice,Waser ^[3] ; Eric P,Krenning ^[4] ; Marion,de Jong ^[5] ; Jean Claude,Reubi ^[3] ; Paul,Cordopatis ^[6] ; Berthold A,Nock ^[2]

作者单位： Molecular Radiopharmacy, INRaSTES, NCSR "Demokritos", GR-15341 Athens, Greece.;Department of Pharmacy, University of Patras, GR-26500 Patras, Greece. ^[1] Molecular Radiopharmacy, INRaSTES, NCSR "Demokritos", GR-15341 Athens, Greece. ^[2] Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland. ^[3] Cyclotron Rotterdam BV, Erasmus MC, 3015 Rotterdam, The Netherlands. ^[4] Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 Rotterdam, The Netherlands. ^[5] Department of Pharmacy, University of Patras, GR-26500 Patras, Greece. ^[6]

关键词 DOTA-conjugated somatostatin [111In]In-radioligand bicyclic somatostatin metabolic stability theranostics tumor targeting